keyword
https://read.qxmd.com/read/38598613/ultrasoft-platelet-like-particles-stop-bleeding-in-rodent-and-porcine-models-of-trauma
#1
JOURNAL ARTICLE
Kimberly Nellenbach, Emily Mihalko, Seema Nandi, Drew W Koch, Jagathpala Shetty, Leandro Moretti, Jennifer Sollinger, Nina Moiseiwitsch, Ana Sheridan, Sanika Pandit, Maureane Hoffman, Lauren V Schnabel, L Andrew Lyon, Thomas H Barker, Ashley C Brown
Uncontrolled bleeding after trauma represents a substantial clinical problem. The current standard of care to treat bleeding after trauma is transfusion of blood products including platelets; however, donated platelets have a short shelf life, are in limited supply, and carry immunogenicity and contamination risks. Consequently, there is a critical need to develop hemostatic platelet alternatives. To this end, we developed synthetic platelet-like particles (PLPs), formulated by functionalizing highly deformable microgel particles composed of ultralow cross-linked poly ( N -isopropylacrylamide) with fibrin-binding ligands...
April 10, 2024: Science Translational Medicine
https://read.qxmd.com/read/38545092/efficacy-and-safety-of-phospholipid-nanoparticles-vbi-s-in-reversing-intractable-hypotension-in-patients-with-septic-shock-a-multicentre-open-label-repeated-measures-phase-2a-clinical-pilot-trial
#2
JOURNAL ARTICLE
Cuthbert Simpkins, Michael Moncure, Heather Klepacz, Kristopher Roach, Sadia Benzaquen, Luis Diaz-Caballero, Jonathan Cohen, Daniel Haase, Mukesh Kumar, Harven DeShield, Anthony Manasia, Juan Rodriguez, Prashanth Anamthathmakula, Nik Hurt, Bhaswati Mukherjee, Krishna Talluri
BACKGROUND: Since the 1990's attempts to favorably modulate nitric oxide (NO) have been unsuccessful. We hypothesized that because NO is lipophilic it would preferentially localize into intravascularly infused hydrophobic nanoparticles, thereby reducing its bioavailability and adverse effects without inhibiting its production. We aimed to determine the efficacy and safety of intravenous infusion of a fluid comprised of hydrophobic phospholipid nanoparticles (VBI-S) that reversibly absorb NO in the treatment of hypotension of patients in severe septic shock...
February 2024: EClinicalMedicine
https://read.qxmd.com/read/38543468/highly-efficient-hemostatic-cross-linked-polyacrylate-polymer-dressings-for-immediate-hemostasis
#3
JOURNAL ARTICLE
Tong Ye, Zhiyuan Yang, Ruolin Hao, Jinnan Guo, Guifang Dou, Zhiyun Meng, Shuchen Liu, Ruolan Gu, Zhuona Wu, Yunbo Sun, Peng Han, Yiguang Jin, Hui Gan
A traumatic hemorrhage is fatal due to the great loss of blood in a short period of time; however, there are a few biomaterials that can stop the bleeding quickly due to the limited water absorption speed. Here, a highly absorbent polymer (HPA), polyacrylate, was prepared as it has the best structure-effectiveness relationship. Within a very short period of time (2 min), HPA continually absorbed water until it swelled up to its 600 times its weight; more importantly, the porous structure comprised the swollen dressing...
March 21, 2024: Polymers
https://read.qxmd.com/read/38472376/identification-of-two-mutant-jason-related-genes-associated-with-unreduced-pollen-production-in-potato
#4
JOURNAL ARTICLE
Corentin R Clot, Lea Vexler, Maria de La O Leyva-Perez, Peter M Bourke, Christel J M Engelen, Ronald C B Hutten, José van de Belt, Erik Wijnker, Dan Milbourne, Richard G F Visser, Martina Juranić, Herman J van Eck
Multiple QTLs control unreduced pollen production in potato. Two major-effect QTLs co-locate with mutant alleles of genes with homology to AtJAS, a known regulator of meiotic spindle orientation. In diploid potato the production of unreduced gametes with a diploid (2n) rather than a haploid (n) number of chromosomes has been widely reported. Besides their evolutionary important role in sexual polyploidisation, unreduced gametes also have a practical value for potato breeding as a bridge between diploid and tetraploid germplasm...
March 12, 2024: TAG. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik
https://read.qxmd.com/read/38465770/elevated-factor-xi-is-associated-with-recurrent-left-ventricular-thrombus-of-unknown-origin
#5
JOURNAL ARTICLE
Łukasz Zandecki, Michał Ząbczyk, Anetta Undas
BACKGROUND: Elevated factor XI (FXI) has been shown to predispose to thromboembolism. We investigated whether it is associated with left ventricular thrombus (LVT) formation, its recurrence and subsequent thromboembolic events. METHODS: In 54 patients with prior LVT of unknown origin, who stopped anticoagulation and 54 controls, we determined FXI, along with plasma clot permeability (Ks ), fibrinolysis time (CLT), endogenous thrombin potential (ETP), von Willebrand factor (vWF) and fibrinolysis proteins...
March 11, 2024: European Journal of Clinical Investigation
https://read.qxmd.com/read/38423578/management-conundrum-in-a-case-of-renal-cell-cancer-rcc-on-dual-antiplatelet-therapy-dapt-for-recently-placed-coronary-drug-eluting-stent-des
#6
JOURNAL ARTICLE
Rudra Prasad Ghorai, Sridhar Panaiyadiyan, Prabhjot Singh, Brusabhanu Nayak
A man in his 50s presented in an emergency with breathlessness and chest discomfort. On evaluation, he was diagnosed with coronary artery disease, with more than 80% narrowing of the right coronary and left circumflex arteries. The patient underwent percutaneous coronary intervention and was started on dual antiplatelet (DAPT) therapy. After starting DAPT, the patient developed gross haematuria with a drop in haematocrit. Further evaluation revealed a left renal mass with urinary bladder clots. Because of the risk of stent thrombosis on stopping DAPT, radical nephrectomy was deferred, and the patient underwent left renal artery angioembolisation and bladder clot evacuation...
February 29, 2024: BMJ Case Reports
https://read.qxmd.com/read/38401649/strategy-to-optimize-periprocedural-anticoagulation-in-structural-transseptal-interventions-design-and-rationale-of-the-stop-clot-trial
#7
JOURNAL ARTICLE
Jerzy Pręgowski, Radosław Pracoń, Aleksandra Mioduszewska, Jarosław Skowroński, Lars Sondergaard, Gary S Mintz, Davide Capodanno, Sang-Wook Kim, Ole De Baker, Piotr Waciński, Wojciech Wojakowski, Adam Rdzanek, Marek Grygier, Michał Chmielecki, Luis Nombela Franco, Patrycjusz Stokłosa, Bohdan Firek, Magdalena Marczak, Barbara Miłosz, Zbigniew Chmielak, Marcin Demkow, Adam Witkowski
BACKGROUND: Both transcatheter edge-to-edge repair (TEER) of mitral regurgitation or left atrial appendage closure (LAAC) require periprocedural anticoagulation with unfractionated heparin (UFH) that is administered either before or immediately after transseptal puncture (TSP). The optimal timing of UFH administration (before or after TSP) is unknown. The Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions trial (STOP CLOT Trial) was designed to determine if early anticoagulation is effective in reducing ischemic complications without increasing the risk of periprocedural bleeding...
February 22, 2024: American Heart Journal
https://read.qxmd.com/read/38398355/simplified-method-for-removing-direct-oral-anticoagulant-interference-in-mechanical-coagulation-test-systems-a-proof-of-concept
#8
JOURNAL ARTICLE
Thomas Exner, Manita Dangol, Emmanuel J Favaloro
BACKGROUND: Direct oral anticoagulants (DOACs) cause unwanted interference in various hemostasis assays, including lupus anticoagulant (LA) testing, where false positive and false negative identification may occur. DOAC Stop (DS) is an activated charcoal (AC) product used to specifically and effectively adsorb DOACs from test plasma. This process normally requires plasma treatment, centrifugation and plasma separation prior to tests, but inexperienced operators may also inadvertently transfer residual AC particles, thereby potentially adversely affecting clot detection...
February 12, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38278032/a-mussel-inspired-polyvinyl-alcohol-collagen-tannic-acid-bioadhesive-for-wet-adhesion-and-hemostasis
#9
JOURNAL ARTICLE
Ying Liu, Chenyu Zhao, Changtong Song, Xiao Shen, Fengji Wang, Yisong Zhang, Yuhong Ma, Xuejia Ding
Bioadhesives are useful in surgery for hemostasis, tissue sealing and wound healing. However, most bioadhesives have limitations such as weak adhesion in wet conditions, insufficient sealing and poor clotting performance. Inspired by the adhesion mechanism of marine mussels, a novel bioadhesive (PCT) was developed by simply combining polyvinyl alcohol (PVA), collagen (COL) and tannic acid (TA) together. The results showed that the adhesion, sealing and blood coagulation properties boosted with the increase of tannic acid content in PCT...
January 24, 2024: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/38256925/chemical-adjustment-of-fibrinolysis
#10
JOURNAL ARTICLE
Alexey M Shibeko, Ivan S Ilin, Nadezhda A Podoplelova, Vladimir B Sulimov, Mikhail A Panteleev
Fibrinolysis is the process of the fibrin-platelet clot dissolution initiated after bleeding has been stopped. It is regulated by a cascade of proteolytic enzymes with plasmin at its core. In pathological cases, the balance of normal clot formation and dissolution is replaced by a too rapid lysis, leading to bleeding, or an insufficient one, leading to an increased thrombotic risk. The only approved therapy for emergency thrombus lysis in ischemic stroke is recombinant tissue plasminogen activator, though streptokinase or urokinase-type plasminogen activators could be used for other conditions...
January 10, 2024: Pharmaceuticals
https://read.qxmd.com/read/38252814/an-architecturally-rational-hemostat-for-rapid-stopping-of-massive-bleeding-on-anticoagulation-therapy
#11
JOURNAL ARTICLE
Vivian K Lee, Taewoo Lee, Amrit Ghosh, Tanmoy Saha, Manish V Bais, Kala Kumar Bharani, Milan Chag, Keyur Parikh, Parloop Bhatt, Bumseok Namgung, Geethapriya Venkataramanan, Animesh Agrawal, Kiran Sonaje, Leo Mavely, Shiladitya Sengupta, Raghunath Anant Mashelkar, Hae Lin Jang
Hemostatic devices are critical for managing emergent severe bleeding. With the increased use of anticoagulant therapy, there is a need for next-generation hemostats. We rationalized that a hemostat with an architecture designed to increase contact with blood, and engineered from a material that activates a distinct and undrugged coagulation pathway can address the emerging need. Inspired by lung alveolar architecture, here, we describe the engineering of a next-generation single-phase chitosan hemostat with a tortuous spherical microporous design that enables rapid blood absorption and concentrated platelets and fibrin microthrombi in localized regions, a phenomenon less observed with other classical hemostats without structural optimization...
January 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38226285/low-flow-ecco-2-r-conjoined-with-renal-replacement-therapy-platform-to-manage-pulmonary-vascular-dysfunction-with-refractory-hypercapnia-in-ards
#12
JOURNAL ARTICLE
Armand Mekontso Dessap, François Bagate, Xavier Repesse, Clarisse Blayau, Muriel Fartoukh, Florence Canoui-Poitrine, Nicolas de Prost, Antoine Vieillard-Baron
BACKGROUND: Hypercapnia worsens lung vascular dysfunction during acute respiratory distress syndrome (ARDS). We tested whether an extracorporeal carbon dioxide removal (ECCO2 R) device based on a renal replacement therapy platform (Prismalung®) may reduce PaCO2 and alleviate lung vascular dysfunction in ARDS patients with refractory hypercapnia. METHODS: We planned to prospectively include 20 patients with moderate-to-severe ARDS, pulmonary vascular dysfunction on echocardiography, and PaCO2 ≥ 48 mmHg despite instrumental dead space reduction and the increase in respiratory rate...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38187217/massive-hemoptysis-in-pregnancy-treated-by-ecmo-combined-with-electronic-bronchoscopy-a-case-report
#13
Keyu Li, Long Wen, Haibo Zhou, Zhiguo Zhou
BACKGROUND: Massive hemoptysis during pregnancy is very rare. Dieulafoy's disease is one of the causes of massive hemoptysis. There are few reports of ECMO use to treat massive hemoptysis during pregnancy. FINDINGS: We report for the first time a patient with Dieulafoy's disease diagnosed at 29 weeks of pregnancy. The patient's hemoptysis occurred rapidly with large volumes. The bleeding amount reached 500 ml within half an hour, with the development of asphyxia and respiratory and cardiac arrest due to a blood clot blocking the airway...
January 15, 2024: Heliyon
https://read.qxmd.com/read/38176451/impact-of-anabolic-androgenic-steroids-on-covid-19
#14
REVIEW
Khaja Moinuddin Shaik, Vijay Patibandla, Sukhendu Nandi
In the wake of the Novel Coronavirus arrival, the world witnessed the fragility of healthcare systems and the resilience of healthcare workers who stood on the front lines. SARS-CoV-2, also known as COVID-19 or severe acute respiratory syndrome, first appeared in China in December 2019. The infection quickly spread across the nation and the world. All countries severely restricted social interaction to stop the virus's transmission, impacting all sporting, social, and recreational activities. Anabolic androgenic steroids (AASs) are frequently used illegally to enhance strength and physical attractiveness...
January 2, 2024: Steroids
https://read.qxmd.com/read/38143056/electrospun-nanofiber-membranes-for-rapid-liver-hemostasis-via-n-alkylated-chitosan-doped-chitosan-peo
#15
JOURNAL ARTICLE
Tao Liu, Shuhan Liu, Yihan Shi, Zhuoran Zhang, Sheng Ding, Kexin Hou, Wen Zhang, Xin Meng, Fan Li
The ideal hemostatic agents should be able to stop bleeding quickly and avoid secondary bleeding caused by adhesion with blood clots during dressing change. Herein, a hydrophobic electrospun nanofiber membrane was prepared for achieving hemostasis, rationally targeting both attributes, via doping N-alkylated chitosan (N-CS) grafted with octadecyl into chitosan/polyethylene oxide (PEO). In vitro and in vivo coagulation tests showed that CPNs doped with small amounts of N-CS (CPN31) could significantly shorten hemostasis time and promote the formation of more stable and stronger blood clots...
December 22, 2023: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38046530/early-treatment-with-fibrinogen-%C3%AE-chain-peptide-coated-adp-encapsulated-liposomes-h12-adp-liposomes-ameliorates-post-partum-hemorrhage-with-coagulopathy-caused-by-amniotic-fluid-embolism-in-rabbits
#16
JOURNAL ARTICLE
Koki Kaneko, Kohsuke Hagisawa, Manabu Kinoshita, Yuka Ohtsuka, Ruka Sasa, Morihiro Hotta, Daizoh Saitoh, Kimiya Sato, Shinji Takeoka, Katsuo Terui
BACKGROUND: Amniotic fluid embolism is an unpredictable and sometimes lethal complication of childbirth. Fibrinogen γ-chain peptide-coated, ADP-encapsulated Liposomes (H12-(ADP)-liposomes), which were developed as a platelet substitute, may be useful to control postpartum hemorrhage with consumptive coagulopathy. OBJECTIVE: This study aimed to establish a hemodynamically stable amniotic fluid embolism animal model and evaluate the efficacy of H12-ADP-liposome infusion in the initial management of postpartum hemorrhage complicated with amniotic fluid embolism-involved coagulopathy...
November 2023: AJOG global reports
https://read.qxmd.com/read/38041691/characterization-of-chitosan-gallic-acid-graft-copolymer-for-periodontal-dressing-hydrogel-application
#17
JOURNAL ARTICLE
Mengge Feng, Xuelian Zeng, Quan Lin, Yunxiao Wang, Hongjiang Wei, Shanyi Yang, Guangwei Wang, Xingyu Chen, Mengqin Guo, Xin Yang, Jun Hu, Yangge Du, Yanbing Zhao, Yufeng Zhang, Xiangliang Yang
The postoperative periodontal wound is in a complex physiological environment, the bacteria accumulation, the saliva stimulation, and the food residues retention will aggravate the wound deterioration. Commercial periodontal dressings have been widely used for postoperative periodontal treatment, and there still exists some problems, such as poor biocompatibility, weak adhesion, insufficient antibacterial and anti-inflammatory properties. In this study, a chitosan-gallic acid graft copolymer (CS-GA) is synthesized as a potential periodontal dressing hydrogel...
December 2, 2023: Advanced Healthcare Materials
https://read.qxmd.com/read/38008144/preparation-and-application-of-hemostatic-microspheres-containing-biological-macromolecules-and-others
#18
REVIEW
Zekai Ren, Yumei Wang, Han Wu, Hailin Cong, Bing Yu, Youqing Shen
Bleeding from uncontrollable wounds can be fatal, and the body's clotting mechanisms are unable to control bleeding in a timely and effective manner in emergencies such as battlefields and traffic accidents. For irregular and inaccessible wounds, hemostatic materials are needed to intervene to stop bleeding. Hemostatic microspheres are promising for hemostasis, as their unique structural features can promote coagulation. There is a wide choice of materials for the preparation of microspheres, and the modification of natural macromolecular materials such as chitosan to enhance the hemostatic properties and make up for the deficiencies of synthetic macromolecular materials makes the hemostatic microspheres multifunctional and expands the application fields of hemostatic microspheres...
November 25, 2023: International Journal of Biological Macromolecules
https://read.qxmd.com/read/37962170/let-s-stop-talking-about-citrate-toxicity
#19
REVIEW
Avantika Israni, David S Goldfarb
PURPOSE OF REVIEW: Continuous renal replacement therapy (CRRT) is a vital medical intervention used in critically ill patients with acute kidney injury (AKI). One of the key components of adequate clearance with CRRT is the use of anticoagulants to prevent clotting of the extracorporeal circuit. Regional citrate anticoagulation is the most often recommended modality. The term 'citrate toxicity' is used to describe potential adverse effects of accumulation of citrate and subsequent hypocalcemia...
March 1, 2024: Current Opinion in Nephrology and Hypertension
https://read.qxmd.com/read/37940896/ligneous-periodontitis-exacerbated-by-beh%C3%A3-et-s-disease-in-a-patient-with-plasminogen-deficiency-and-a-stop-gained-variant-plg-c-1468c%C3%A2-%C3%A2-t-a-case-report
#20
JOURNAL ARTICLE
Yuki Shinoda-Ito, Anna Hirai, Kazuhiro Omori, Hidetaka Ideguchi, Hideki Yamamoto, Fumino Kato, Kyoichi Obata, Tatsuo Ogawa, Keisuke Nakano, Takato Nakadoi, Eri Katsuyama, Soichiro Ibaragi, Tadashi Yamamoto, Hitoshi Nagatsuka, Akira Hirasawa, Shogo Takashiba
BACKGROUND: Plasminogen serves as the precursor to plasmin, an essential element in the fibrinolytic process, and is synthesized primarily in the liver. Plasminogen activation occurs through the action of plasminogen activator, converting it into plasmin. This conversion greatly enhances the fibrinolytic system within tissues and blood vessels, facilitating the dissolution of fibrin clots. Consequently, congenital deficiency of plasminogen results in impaired fibrin degradation. Patients with plasminogen deficiency typically exhibit fibrin deposits in various mucosal sites throughout the body, including the oral cavity, eyes, vagina, and digestive organs...
November 8, 2023: BMC Oral Health
keyword
keyword
92812
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.